SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...
Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...
Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...
In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...
The facility, known as Modulus, can switch between making different vaccines or treatments in a matter of days. It will contribute about 200 skilled jobs to Singapore, and will be fully ...